Intervention

Midodrine

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting1

Common conditions8

Lead sponsors shown2

Clinical trials

3 shown

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic FailureNCT02897063 · 2016-09-01

RECRUITING

Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure PatientsNCT04620382 · 2020-11-09

COMPLETED

Treatment of Orthostatic Intolerance in Patients With Parkinson's Disease Using MidodrineNCT02365012 · 2014-04-01

UNKNOWN

Common conditions

Autonomic Failure2 Multiple System Atrophy2 Parkinson Disease2 Pure Autonomic Failure2 Neurogenic Orthostatic Hypotension1 Orthostatic Hypotension1 Orthostatic Intolerance1 Parkinson's Disease1

Leading sponsors

Vanderbilt University Medical Center 2 Corporal Michael J. Crescenz VA Medical Center 1

Trial status mix

COMPLETED1

RECRUITING1

UNKNOWN1

Phase mix

EARLY_PHASE11

NA1

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.